{
    "id": 2700,
    "fullName": "GATA1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "GATA1 over exp indicates an over expression of the Gata1 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2623,
        "geneSymbol": "GATA1",
        "terms": [
            "GATA1",
            "ERYF1",
            "GATA-1",
            "GF-1",
            "GF1",
            "NF-E1",
            "NFE1",
            "XLANP",
            "XLTDA",
            "XLTT"
        ]
    },
    "variant": "over exp",
    "createDate": "12/08/2014",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1428,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, high expression of GATA1 was associated with decreased sensitivity to Cytosar-U (cytarabine) in an non-Down Syndrome megakaryocytic leukemia cell line in culture (PMID: 23874683).",
            "molecularProfile": {
                "id": 2519,
                "profileName": "GATA1 over exp"
            },
            "therapy": {
                "id": 712,
                "therapyName": "Cytarabine",
                "synonyms": null
            },
            "indication": {
                "id": 8761,
                "name": "megakaryocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 1278,
                    "pubMedId": 23874683,
                    "title": "Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23874683"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 1429,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, high expression of GATA1 was associated with decreased sensitivity to Cerubidine (daunorubicin) in a non-Down Syndrome megakaryocytic leukemia cell line in culture (PMID: 23874683).",
            "molecularProfile": {
                "id": 2519,
                "profileName": "GATA1 over exp"
            },
            "therapy": {
                "id": 1006,
                "therapyName": "Daunorubicin",
                "synonyms": null
            },
            "indication": {
                "id": 8761,
                "name": "megakaryocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 1278,
                    "pubMedId": 23874683,
                    "title": "Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23874683"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2519,
            "profileName": "GATA1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}